Auxano Advisors LLC Invests $239,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Auxano Advisors LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 454 shares of the healthcare conglomerate’s stock, valued at approximately $239,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Richelieu Gestion SA acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Robbins Farley purchased a new stake in UnitedHealth Group in the third quarter valued at $25,000. CGC Financial Services LLC lifted its holdings in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC grew its holdings in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after purchasing an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA boosted its position in UnitedHealth Group by 148.1% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on UNH. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Morgan Stanley decreased their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a report on Friday, April 5th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Stephens reissued an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research report on Thursday, February 8th. Finally, TD Cowen cut their price target on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $570.05.

Read Our Latest Report on UnitedHealth Group

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Down 1.1 %

UNH traded down $5.33 on Tuesday, reaching $483.70. 3,233,270 shares of the company’s stock were exchanged, compared to its average volume of 4,463,564. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company’s 50 day moving average is $485.19 and its 200-day moving average is $513.81. The company has a market cap of $445.04 billion, a price-to-earnings ratio of 29.63, a PEG ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the firm posted $6.26 earnings per share. UnitedHealth Group’s revenue for the quarter was up 8.6% compared to the same quarter last year. Equities analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.55%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.